Ahmad AA, Draves SO, Rosca M
Glucagon inhibits gastric motility and is believed to act directly on the beta cells to contribute to glucose competence of insulin release [19]
For Canadians managing chronic conditions over many months, this difference translates to significant savings
The ADA adds a notable new 2026 recommendation: simultaneous initiation of SGLT-2i and nsMRA can be considered in patients with T2D, UACR 100 mg/g, and eGFR 3090 while on a RAS inhibitor
Boucher J, Kleinridders A, Kahn CR
Glutathione administered intravenously, inhaled, and ingested intranasally increases systemic levels.27 IV glutathione has a short half-life but has shown at least short-term efficacy in several diseases